DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by a huge potential in the CGM market. A strong ...

Q3 2025 Earnings Call Transcript October 30, 2025 DexCom, Inc. beats earnings expectations. Reported EPS is $0.61, ...

DexCom (DXCM) is forecasting robust earnings growth of 19.2% per year and revenue growth of 11.8% per year. Both figures outpace the broader US market’s revenue growth forecast of 10.4%. Over the past ...

Tidepool today announced a strategic collaboration with Oura to support a groundbreaking dataset for diabetes research.

Thank you, operator, and welcome to DexCom's Third Quarter 2025 Earnings Call. Our agenda begins with Jake Leach, DexCom's President and Interim CEO, who will summarize our recent highlights and ...

December S&P 500 E-Mini futures (ESZ25) are up +0.42%, and December Nasdaq 100 E-Mini futures (NQZ25) are up +0.57% this ...

A defense tech darling's stock surged on Monday, Nov. 10, 2025, amid hopes that the government may reopen soon, while comments from President Trump calling for changes to health care payments dragged ...

A potential IPO would cement the Boston-based company as a leader in the wearables and wellness space, particularly in a ...

13 analysts have expressed a variety of opinions on DexCom (NASDAQ:DXCM) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below provides a snapshot of their ...

Shares of DexCom Inc. DXCM shed 1.98% to $69.23 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.23% to 6,890.89 and the Dow ...

Shares of DexCom Inc. DXCM slid 1.03% to $70.33 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.79% to 6,791.69 and the ...